Overhaul of Baillie Gifford European Growth Trust continues
'Covid is not going away': Virologist fund manager Dr Ogden on coronavirus, healthcare valuations and biotech opportunities
Single vaccine 'not enough' to treat patients
Market breadth in S&P 500 has 'never been so narrow'
Global Income fund overweight in mega-cap US stocks
Which frameworks can investors use to navigate markets?
Two stocks kicked out
Consumer goods and tech companies get support